Tagged with manufactu

Ukraine Dmytro Popov, the owner, founder and CEO Elfa Group, Ukraine’s leading cosmetics manufacturer, provides his insight into Elfa’s 20-year presence in the Ukrainian market, the company’s international growth strategies and how it can further strengthen its market positioning. Could you begin by introducing yourself and your company? “Our goal is…

Ukraine Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that he has been implementing in the country over the past 25 years. Leveraging its long-standing experience of the Ukrainian market,…

Indonesia Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the sales growth rate achieved by Darya-Varia Laboratoria was 11 percent, above market average. What business approach is the secret to…

Hong Kong William Lai YF, CEO of Fortune Pharmacal, discusses the Hong Kong OTC market, the company’s internationalization strategy, and its expanding manufacturing footprint. Could you please introduce us to Fortune Pharmacal? What sets you apart from other OTC companies? “We follow the highest standards by always exploring what the ‘big boys’…

Ukraine Anatoliy Novyk, founder and president of SMC Ecopharm, the only Ukrainian pharmaceutical company to be exclusively focused on its own original drug development, provides insights into Ecopharm’s promising expansion strategy, which should be significantly propelled by the company’s upcoming GMP-certified manufacturing plant. He also provides an in-depth look into their…

Indonesia Aylie Widjaja, managing director at Exeltis Indonesia, shares her excitement about developing the company’s footprint in Indonesia, making it a manufacturing hub for Asia, and highlights the challenges in navigating the public market. How do you see the Indonesian healthcare landscape evolving? “We have to give better options to patients…

Ukraine Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as Ukraine’s largest domestic company and the market leader in the country since 2010. She also documents the impact of the…

Colombia Emilio Sardi, vice-president of Tecnoquimicas, the local champion in production and distribution of generic pharmaceutical drugs, shares his insights on his current priorities to enter the biotechnology field, grow their international operations focusing on Central American countries and further strengthen the company’s exceptional capacity to launch new products.   The…

Ukraine Anatoliy Reder, founder and general director of InterChem, provides insights into the heightened international ambitions of this leading, science-based Ukrainian pharmaceutical company, which plans to leverage its unique R&D and manufacturing capacities to bring to the EU and other international markets their in-house developed, original products, which proudly stand as…

Ukraine Eugene Zaika, general director Ukraine and CIS of Pharma Start, a company acquired in October 2015 by Swiss-headquartered Acino Group and one of the leading players in Ukraine, provides insights into the group’s countercyclical investments in Ukraine, while Pharma Start’s ongoing successes prove that the risk taken is actually paying…

Ukraine Ludmila Bezpalko, CEO of Borshchahivskiy Chemical Pharmaceutical Plant (BCPP), a top 10 domestic pharmaceutical company in Ukraine, documents the development strategy she has been following over the past two decades to ensure BCCP now proudly stands as the Ukrainian leader in terms of international standards and quality certifications. She also…

Indonesia Jonathan Sudharta, member of the the Board of Directors at Mensa Group, shares insights on the vertical integration strategy of Mensa to offer an end-to-end solution as well as shows how the new investment in Halodoc – a disruptive healthcare mobile application – will help the group to be closer…